Medtronic has announced FDA approval of its Omniasecure defibrillation lead, a device that connects to implantable cardioverter...

Field Medical raised $40 million to advance its pulsed field ablation technology for ventricular tachycardia, aiming to address a major unmet need in cardiac arrhythmia treatment.

Edwards Lifesciences has received CE mark approval in Europe for its Sapien M3 transcatheter mitral valve replacement system, expanding its mitral and tricuspid therapy portfolio as it targets $2 billion in global sales by 2030.

Illumina and Tempus AI have partnered to expand the use of genomic testing and precision medicine beyond oncology into broader disease areas like cardiology, neurology, and rare disorders.

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device,.

J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, Boston Scientific agreed to buy Bolt Medical in January.

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems.